1. NelsonJA, GnannJWJr, GhazalP (1990) Regulation and tissue-specific expression of human cytomegalovirus. Curr Top Microbiol Immunol 154: 75–100.
2. BoehlerA, SchaffnerA, SalomonF, KeuschG (1994) Cytomegalovirus disease of late onset following renal transplantation: a potentially fatal entity. Scand J Infect Dis 26: 369–373.
3. BallardRA, DrewWL, HufnagleKG, RiedelPA (1979) Acquired cytomegalovirus infection in preterm infants. Am J Dis Child 133: 482–485.
4. AdlerSP (1983) Transfusion-associated cytomegalovirus infections. Rev Infect Dis 5: 977–993.
5. EinhornL, OstA (1984) Cytomegalovirus infection of human blood cells. J Infect Dis 149: 207–214.
6. MacherAM, ReichertCM, StrausSE, LongoDL, ParrilloJ, et al. (1983) Death in the AIDS patient: role of cytomegalovirus. N Engl J Med 309: 1454.
7. NeimanP, WassermanPB, WentworthBB, KaoGF, LernerKG, et al. (1973) Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation. Transplantation 15: 478–485.
8. TegtmeierGE (1988) The use of cytomegalovirus-screened blood in neonates. Transfusion 28: 201–203.
9. LarssonS, Soderberg-NauclerC, WangFZ, MollerE (1998) Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 38: 271–278.
10. Soderberg-NauclerC, FishKN, NelsonJA (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91: 119–126.
11. StanierP, KitchenAD, TaylorDL, TymsAS (1992) Detection of human cytomegalovirus in peripheral mononuclear cells and urine samples using PCR. Mol Cell Probes 6: 51–58.
12. Taylor-WiedemanJ, SissonsJG, BorysiewiczLK, SinclairJH (1991) Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72 (Pt 9) 2059–2064.
13. MyersonD, HackmanRC, NelsonJA, WardDC, McDougallJK (1984) Widespread presence of histologically occult cytomegalovirus. Hum Pathol 15: 430–439.
14. GoodrumF, CavinessK, ZagalloP (2012) Human cytomegalovirus persistence. Cell Microbiol 14: 644–655.
15. GrundhoffA, SullivanCS (2011) Virus-encoded microRNAs. Virology 411: 325–343.
16. DunnW, TrangP, ZhongQ, YangE, van BelleC, et al. (2005) Human cytomegalovirus expresses novel microRNAs during productive viral infection. Cell Microbiol 7: 1684–1695.
17. GreyF, AntoniewiczA, AllenE, SaugstadJ, McSheaA, et al. (2005) Identification and characterization of human cytomegalovirus-encoded microRNAs. J Virol 79: 12095–12099.
18. MesheshaMK, Veksler-LublinskyI, IsakovO, ReichensteinI, ShomronN, et al. (2012) The microRNA Transcriptome of Human Cytomegalovirus (HCMV). Open Virol J 6: 38–48.
19. PfefferS, SewerA, Lagos-QuintanaM, SheridanR, SanderC, et al. (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269–276.
20. StarkTJ, ArnoldJD, SpectorDH, YeoGW (2012) High-resolution profiling and analysis of viral and host small RNAs during human cytomegalovirus infection. J Virol 86: 226–235.
21. TuddenhamL, PfefferS (2011) Roles and regulation of microRNAs in cytomegalovirus infection. Biochim Biophys Acta 1809: 613–622.
22. GreyF, MeyersH, WhiteEA, SpectorDH, NelsonJ (2007) A Human Cytomegalovirus-Encoded microRNA Regulates Expression of Multiple Viral Genes Involved in Replication. PLoS Pathog 3: e163.
23. BellareP, GanemD (2009) Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6: 570–575.
24. LeiX, BaiZ, YeF, XieJ, KimCG, et al. (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12: 193–199.
25. LuF, StedmanW, YousefM, RenneR, LiebermanPM (2010) Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J Virol 84: 2697–2706.
26. MurphyE, VanicekJ, RobinsH, ShenkT, LevineAJ (2008) Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci U S A 105: 5453–5458.
27. Stern-GinossarN, ElefantN, ZimmermannA, WolfDG, SalehN, et al. (2007) Host immune system gene targeting by a viral miRNA. Science 317: 376–381.
28. KarginovFV, ConacoC, XuanZ, SchmidtBH, ParkerJS, et al. (2007) A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci U S A 104: 19291–19296.
29. GreyF, TirabassiR, MeyersH, WuG, McWeeneyS, et al. (2010) A viral microRNA down-regulates multiple cell cycle genes through mRNA 5′UTRs. PLoS Pathog 6: e1000967.
30. DolkenL, MaltererG, ErhardF, KotheS, FriedelCC, et al. (2010) Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7: 324–334.
31. FarhKK, GrimsonA, JanC, LewisBP, JohnstonWK, et al. (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310: 1817–1821.
32. LewisBP, BurgeCB, BartelDP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15–20.
33. LimLP, LauNC, Garrett-EngeleP, GrimsonA, SchelterJM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769–773.
34. LimJH, ParkJW, KimSJ, KimMS, ParkSK, et al. (2007) ATP6V0C competes with von Hippel-Lindau protein in hypoxia-inducible factor 1alpha (HIF-1alpha) binding and mediates HIF-1alpha expression by bafilomycin A1. Mol Pharmacol 71: 942–948.
35. GottweinE, CorcoranDL, MukherjeeN, SkalskyRL, HafnerM, et al. (2011) Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10: 515–526.
36. HaeckerI, GayLA, YangY, HuJ, MorseAM, et al. (2012) Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog 8: e1002884.
37. RileyKJ, RabinowitzGS, YarioTA, LunaJM, DarnellRB, et al. (2012) EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J 31: 2207–2221.
38. SkalskyRL, CorcoranDL, GottweinE, FrankCL, KangD, et al. (2012) The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog 8: e1002484.
39. KimY, LeeS, KimS, KimD, AhnJH, et al. (2012) Human cytomegalovirus clinical strain-specific microRNA miR-UL148D targets the human chemokine RANTES during infection. PLoS Pathog 8: e1002577.
40. LeeSH, KalejtaRF, KerryJ, SemmesOJ, O'ConnorCM, et al. (2012) BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection. Proc Natl Acad Sci U S A 109: 9575–9580.
41. ForgacM (2007) Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 8: 917–929.
42. RyckmanBJ, JarvisMA, DrummondDD, NelsonJA, JohnsonDC (2006) Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol 80: 710–722.
43. SanchezV, GreisKD, SztulE, BrittWJ (2000) Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly. J Virol 74: 975–986.
44. Stern-GinossarN, SalehN, GoldbergMD, PrichardM, WolfDG, et al. (2009) Analysis of human cytomegalovirus-encoded microRNA activity during infection. J Virol 83: 10684–10693.
45. BenarochP, YillaM, RaposoG, ItoK, MiwaK, et al. (1995) How MHC class II molecules reach the endocytic pathway. EMBO J 14: 37–49.
46. MacfarlaneDE, ManzelL (1998) Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J Immunol 160: 1122–1131.
47. UmashankarM, PetrucelliA, CicchiniL, CaposioP, KreklywichCN, et al. (2011) A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection. PLoS Pathog 7: e1002444.
48. EasowG, TelemanAA, CohenSM (2007) Isolation of microRNA targets by miRNP immunopurification. Rna 13: 1198–1204.
49. RehmsmeierM, SteffenP, HochsmannM, GiegerichR (2004) Fast and effective prediction of microRNA/target duplexes. Rna 10: 1507–1517.
50. RueCA, JarvisMA, KnocheAJ, MeyersHL, DeFilippisVR, et al. (2004) A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J Virol 78: 12529–12536.